Loading
Innospec Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 17 Nov 2025.
Innospec Inc.: what insiders have been doing
This page follows insider dealings at Innospec Inc. as filed with SEC (Form 4), a company from the Chemicals & Materials sector based in United States, United States. The group dates from 1999. From 18 October 2025 to 18 October 2026, the disclosure feed for Innospec Inc. logged 31 filings by 11 insiders.
The record shows 1 purchase on the open market worth €22k, made by 1 insider, against 10 sales worth €411k by 5 insiders. Taken together, the sales exceed the purchases by €390k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Biggest ticket of the year: €154k, sold by Cleminson Ian and made public on 3 March 2026. Among those who bought: 1 senior executive.
Across the 5,811 companies tracked on its exchange, the median is 19 filings; at 31 filings, this issuer sits above that mark. Since 2021, the database holds 10 purchases and 24 sales by insiders of the company. The 10-K for the year ended 31 December 2025 shows 1.78 bn USD of revenue and 116.6 m USD of net income and a dividend of 1.71 USD per share.
The latest purchase dates back some time: it was published 335 days ago, on 17 November 2025. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
In the same sector, recent insider purchases at Culp Inc also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
168
Thresholds
n/a
Buy Volume
€483,366
10 ops. · all time
Sell Volume
€3M
24 ops. · all time
Who traded when
BuySaleIan Cleminson3 sales
Larry PADFIELD3 sales
Milton C. Blackmore3 sales
Claudia Poccia2 sales
David Landless2 sales
Leslie J. Parrette1 buy1 sale
+2 other insiders
Since the insiders bought
- +21.1%Entry US$71.15 · Close at T+90 US$86.14
- +24.2%Entry US$101.31 · Close at T+365 US$125.81
- +12.2%Entry US$111.35 · Close at T+365 US$124.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,302 of 24,148 companies
57.3
score / 100
Value54
Quality61
FCF yld2.6%
Earn yld4.8%
EV/EBITDA12.4x
ROE9.1%
Gross mgn28%
Net mgn6.6%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$98.55
Analyst consensus
3 analysts1.33/5
US$93.00Target US$101.00(+2%)US$110.00
Income statement
RevenueUS$1.8B
Gross profitUS$492.4M28% margin
EBITDAUS$199.9M11% margin
Net incomeUS$116.6M6.6% margin
Valuation
PER (trailing)19.9x
PER (forward)16.0x
P/Book1.8x
Beta0.89
Balance sheet & cash
Market capUS$2.4B
Total debtUS$52.7M
Free Cash FlowUS$62.8M
Debt / Equity4%
Profitability & ownership
ROE9.1%
ROA5.1%
% insiders1.3%
% institutions102.3%
Last declaration on 6 March 2026
Declarations168 total
287 shares@ US$76.300.0010% mcap9.4% of flowCommon StockSEC:0001193125-26-097170:0
57 shares@ US$76.300.0002% mcap5.5% of flowCommon StockSEC:0001193125-26-096992:0
1,149 shares@ US$76.300.0039% mcap4.8% of flowCommon StockSEC:0001193125-26-096980:0
287 shares@ US$76.300.0010% mcap6.9% of flowCommon StockSEC:0001193125-26-097180:0
287 shares@ US$76.300.0010% mcap11.0% of flowCommon StockSEC:0001193125-26-096987:0
594 shares@ US$76.556214.2% of flowCommon StockSEC:0001193125-26-089359:0
594 shares@ US$76.556222.7% of flowCommon StockSEC:0001193125-26-089280:0
119 shares@ US$76.556211.5% of flowCommon StockSEC:0001193125-26-089317:0
401 shares@ US$78.349.3% of flowCommon StockSEC:0001193125-26-089295:0
2,380 shares@ US$76.5610.0% of flowCommon StockSEC:0001193125-26-089095:0
7,966 shares@ US$78.3414.0% of flowCommon StockSEC:0001193125-26-089087:0
875 shares@ US$78.349.1% of flowCommon StockSEC:0001193125-26-089161:0
166 shares@ US$78.342.3% of flowCommon StockSEC:0001193125-26-089116:0
594 shares@ US$76.556219.4% of flowCommon StockSEC:0001193125-26-089348:0
2,481 shares0Common StockSEC:0001193125-26-072493:0
2,521 shares0Common StockSEC:0001193125-26-072465:0
4,499 shares0Common StockSEC:0001193125-26-072437:0
20,846 shares0Common StockSEC:0001193125-26-072309:0
2,993 shares0Common StockSEC:0001193125-26-072295:0
1,539 shares0Common StockSEC:0001193125-26-072169:0
1,539 shares0Common StockSEC:0001193125-26-067786:0
1,539 shares0Common StockSEC:0001193125-26-067764:0
1,030 shares@ US$44.1814.3% of flowCommon StockSEC:0001193125-26-067750:0
1,030 shares@ US$44.1819.5% of flowCommon StockSEC:0001193125-26-067734:0
1,539 shares0Common StockSEC:0001193125-26-067804:0
25 of 168 declarations
About Innospec Inc.
INNOSPEC INC. (ticker: IOSP) is a U.S.-based specialty chemicals company listed on the NASDAQ in the United States. For French-speaking investors, Innospec is best understood as a niche industrial chemistry platform where competitive advantage comes from formulation expertise, regulatory compliance, application know-how and customer service rather than pure scale. The company’s principal headquarters are in Englewood, Colorado, anchoring it firmly in the U.S. industrial landscape while operating with a broad global footprint.
Innospec’s business is organized into three core segments. Fuel Specialties develops, manufactures and sells fuel additives used in diesel, jet, marine, fuel oil and other fuel applications. These products are designed to improve fuel efficiency, enhance engine performance and reduce harmful emissions. Performance Chemicals supplies technology-based solutions for personal care, home care, agrochemicals, construction, mining and other industrial markets. Oilfield Services provides specialty chemicals for upstream oil and gas operations, including drilling, completion, production and drag-reducing agents.
Read moreShow less
From a historical perspective, Innospec has evolved as a specialist in additives and formulation chemistry, building a long-standing technical culture around product performance and customer-specific solutions. The company operates across the Americas, Europe, the Middle East, Africa and Asia-Pacific, with manufacturing, research and commercial support capabilities spread across multiple countries. Its competitive position is supported by deep technical expertise, sticky customer relationships, and the ability to serve regulated end markets where product qualification and reliability matter.
Recent company disclosures show that Innospec continued to emphasize innovation and portfolio development. The company highlighted new product activity, including the LaZuli™ product line for deepwater subsea production, and referenced production expansions in certain areas. In its 2024 reporting, Innospec generated $1.845 billion of net sales, with Fuel Specialties and Performance Chemicals providing important earnings support, while Oilfield Services declined in a softer energy-services environment. That mix underscores the company’s partial insulation from any single end market, even though cyclicality remains visible.
Operationally, the 2024 results also indicated stronger profitability in Performance Chemicals and Fuel Specialties, helping offset weakness in Oilfield Services. For investors, IOSP is a specialized chemical manufacturer with a diversified end-market exposure, a global operating base and a focus on performance-driven, often regulatory-sensitive products. Its profile is consistent with a mid-cap industrial compounder rather than a commodity chemical player, and recent insider-trading Form 4 activity should be read in that context of ongoing market attention and shareholder monitoring.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
